ID: ALA4585500

Max Phase: Preclinical

Molecular Formula: C16H17FN2O5S

Molecular Weight: 368.39

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  CCOc1cc(OC)cc(C(=O)NNS(=O)(=O)c2ccccc2F)c1

Standard InChI:  InChI=1S/C16H17FN2O5S/c1-3-24-13-9-11(8-12(10-13)23-2)16(20)18-19-25(21,22)15-7-5-4-6-14(15)17/h4-10,19H,3H2,1-2H3,(H,18,20)

Standard InChI Key:  LMTBKXLCGOPLTE-UHFFFAOYSA-N

Associated Targets(Human)

Histone acetyltransferase KAT6A 320 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 368.39Molecular Weight (Monoisotopic): 368.0842AlogP: 1.86#Rotatable Bonds: 7
Polar Surface Area: 93.73Molecular Species: ACIDHBA: 5HBD: 2
#RO5 Violations: 0HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 3.85CX Basic pKa: CX LogP: 2.03CX LogD: 1.80
Aromatic Rings: 2Heavy Atoms: 25QED Weighted: 0.73Np Likeness Score: -1.96

References

1. Priebbenow DL, Leaver DJ, Nguyen N, Cleary B, Lagiakos HR, Sanchez J, Xue L, Huang F, Sun Y, Mujumdar P, Mudududdla R, Varghese S, Teguh S, Charman SA, White KL, Shackleford DM, Katneni K, Cuellar M, Strasser JM, Dahlin JL, Walters MA, Street IP, Monahan BJ, Jarman KE, Jousset Sabroux H, Falk H, Chung MC, Hermans SJ, Downer NL, Parker MW, Voss AK, Thomas T, Baell JB..  (2020)  Discovery of Acylsulfonohydrazide-Derived Inhibitors of the Lysine Acetyltransferase, KAT6A, as Potent Senescence-Inducing Anti-Cancer Agents.,  63  (9): [PMID:32118427] [10.1021/acs.jmedchem.9b02071]

Source